Effects of Livagen peptide on chromatin activation in lymphocytes from old people.
Khavinson VKh, Lezhava TA, Monaselidze JG, Dzhokhadze TA, Dvalishvili NA, Bablishvili NK, Ryadnova IY · 2002 · Bulletin of experimental biology and medicine · PMID 12533768
What does this source report?
Livagen altered chromatin organization and ribosomal-gene activity in donor-derived lymphocytes.
- Population and setting
- Cultured lymphocytes from older donors
- Evidence type
- In vitro
- Preparation
- See the original report; formulation details require verification.
- Source language
- English indexed abstract; original language:
- Title provenance
- Title as recorded in the linked source or index. A separate original-language title has not been transcribed unless shown above.
What are the limitations?
- Cells from human donors are not a human treatment trial; rejuvenation and liver benefit were not established.
- Full methods, reporting completeness and independent replication remain to be appraised.
Publication counts are not counts of independent trials. Reviews, translations and reports sharing participants may overlap. Findings apply to the studied preparation, population and endpoints.
Review depth: Abstract reviewed
Source access and review scope
Primary citation and indexed abstract reviewed through Europe PMC. Full article not appraised.
Recorded source-check date: 2026-10-05. This date does not imply a completed systematic review.
Source provenance: Original journal report
Cite and trace this record
Original source: Khavinson VKh, Lezhava TA, Monaselidze JG, Dzhokhadze TA, Dvalishvili NA, Bablishvili NK, Ryadnova IY. Effects of Livagen peptide on chromatin activation in lymphocytes from old people. Bulletin of experimental biology and medicine · PMID 12533768 2002.
Molekul research summary: https://molekul.io/research/audit-12533768. Cite the original publication for its findings and this page when referring to Molekul’s summary or evidence appraisal.
Bibliography entry